|
Index of reports
> Cases resulting in life threatening events (33)
> Cases with Somnolence (7)
Below is the selection of adverse event reports related to Neurontin (Gabapentin) that includes cases resulting in life threatening events where reactions include somnolence.
Adverse event in male receiving Neurontin (Gabapentin)
Reported by a individual with unspecified qualification from Philippines on 2007-07-16
Patient: male, weighing 75.0 kg (165.0 pounds)
Adverse reactions / side effects: Dysarthria, Trismus, Fatigue, Somnolence
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Neurontin (Gabapentin)
Other drugs received by patient: Thiamine HCL; Vitamin B6; Vitamin B-12; Mefenamic Acid
Adverse event in male receiving Neurontin (Gabapentin)
Reported by a individual with unspecified qualification from Philippines on 2007-06-22
Patient: male, weighing 75.0 kg (165.0 pounds)
Adverse reactions / side effects: Dysarthria, Trismus, Fatigue, Somnolence
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Neurontin (Gabapentin)
Other drugs received by patient: Thiamine HCL; Vitamin B6; Vitamin B-12; Mefenamic Acid
Adverse event in male receiving Neurontin (Gabapentin)
Reported by a individual with unspecified qualification from Philippines on 2007-06-22
Patient: male, weighing 75.0 kg (165.0 pounds)
Adverse reactions / side effects: Dysarthria, Trismus, Fatigue, Somnolence
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Neurontin (Gabapentin)
Other drugs received by patient: Thiamine HCL; Vitamin B6; Vitamin B-12; Mefenamic Acid
Adverse event in male receiving Neurontin (Gabapentin)
Reported by a individual with unspecified qualification from Philippines on 2007-06-05
Patient: male, weighing 75.0 kg (165.0 pounds)
Adverse reactions / side effects: Dysarthria, Trismus, Fatigue, Somnolence
Adverse event resulted in: life threatening event
Suspect drug(s):
Neurontin (Gabapentin)
Adverse event in female receiving Neurontin (Gabapentin)
Reported by a consumer/non-health professional from United States on 2007-02-09
Patient: female, weighing 52.2 kg (114.8 pounds)
Adverse reactions / side effects: Confusional State, Head Injury, Abasia, Dyskinesia, Pain, Headache, Wound Haemorrhage, Somnolence, Fall, Fatigue, Vascular Calcification, Balance Disorder, Musculoskeletal Stiffness, Adverse Event, Dizziness, Drug Level Changed, Mass, Laceration, Cerebrovascular Accident, Amnesia, Convulsion, Asthenia, Arthritis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Neurontin
Lyrica
Administration route: Oral
Indication: Neuropathy
Start date: 2006-07-18
End date: 2006-08-07
Coumadin
Other drugs received by patient: Zocor; Cozaar; Plavix; Coreg; Digitek; Prednisone; Aspirin; Valium
Adverse event in male receiving Neurontin (Gabapentin)
Reported by a consumer/non-health professional from United States on 2007-02-06
Patient: male, weighing 108.9 kg (239.6 pounds)
Adverse reactions / side effects: Pneumonia Aspiration, Drug Ineffective, Intentional Overdose, Mental Status Changes, Somnolence, Hypokalaemia, Drug Toxicity, Completed Suicide, Injury, Depression, Metabolic Acidosis, Hypotension, Drug Abuser, Respiratory Distress, Grand MAL Convulsion, Psychotic Disorder, Respiratory Failure
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Neurontin
Indication: Diabetic Neuropathy
Neurontin
Indication: Pain
Celebrex
Indication: Osteoarthritis
Paxil
Indication: Depression
Amitriptyline with Perphenazine
Indication: Depression
Oxycontin
Indication: Pain
Paracetamol
Other drugs received by patient: Nexium; Baclofen; Insulin; Duragesic; Glucophage; Vioxx; Ultram; Risperdal; Ambien; Percocet; Methocarbamol; Relafen; Clonidine; Wellbutrin
Adverse event in male receiving Neurontin (Gabapentin)
Reported by a physician from Germany on 2007-01-12
Patient: male, weighing 72.0 kg (158.4 pounds)
Adverse reactions / side effects: Myoclonus, Overdose, Respiratory Disorder, Unresponsive TO Stimuli, Somnolence, Convulsion
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Neurontin
Dosage: daily dose:900mg
Administration route: Oral
Indication: Diabetic Neuropathy
Start date: 2006-10-01
End date: 2006-11-19
Neurontin
Indication: Epilepsy
|
